Erkan, B.; MacIntyre, S.; Brown, C.; Fakroun, A.; Lashen, A.G.; Mongan, N.P.; Ellis, I.O.; Rakha, E.A.; Green, A.R.
Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer. Int. J. Mol. Sci. 2024, 25, 11572.
https://doi.org/10.3390/ijms252111572
AMA Style
Erkan B, MacIntyre S, Brown C, Fakroun A, Lashen AG, Mongan NP, Ellis IO, Rakha EA, Green AR.
Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer. International Journal of Molecular Sciences. 2024; 25(21):11572.
https://doi.org/10.3390/ijms252111572
Chicago/Turabian Style
Erkan, Busra, Skye MacIntyre, Charlotte Brown, Ali Fakroun, Ayat G. Lashen, Nigel P. Mongan, Ian O. Ellis, Emad A. Rakha, and Andrew R. Green.
2024. "Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer" International Journal of Molecular Sciences 25, no. 21: 11572.
https://doi.org/10.3390/ijms252111572
APA Style
Erkan, B., MacIntyre, S., Brown, C., Fakroun, A., Lashen, A. G., Mongan, N. P., Ellis, I. O., Rakha, E. A., & Green, A. R.
(2024). Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer. International Journal of Molecular Sciences, 25(21), 11572.
https://doi.org/10.3390/ijms252111572